Dissolvable microneedle patches for the delivery of cell-culture-derived influenza vaccine antigens

Journal of Pharmaceutical Sciences

Volumn 101, Issue 3, 2012, Pages 1021-1027

  Kommareddy, Sushma ^a   Baudner, Barbara C ^b   Oh, Seajin ^c   Kwon, Sung Yun ^c   Singh, Manmohan ^a   O'Hagan, Derek T ^a  

^a Vaccines Research   (United States)

^b NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^c TheraJect Inc   (United States)

Author keywords

Influenza vaccine; Microneedles

Indexed keywords

CARBOXYMETHYLCELLULOSE; INFLUENZA VACCINE; TREHALOSE; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMAGGLUTINATION INHIBITION; IMMUNE RESPONSE; IMMUNODIFFUSION; IMMUNOGENICITY; IN VIVO STUDY; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; MASS SPECTROMETRY; MICRONEEDLE PATCH; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN STABILITY; SEASONAL INFLUENZA; VIRUS NEUTRALIZATION;

EID: 84855876634     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23019     Document Type: Article

References (18)

1. Nicholson KG, Wood JM, Zambon M. 2003. Influenza. Lancet 362(9397):1733-1745.
2. Hale BG, Albrecht RA, Garcia-Sastre A. 2010. Innate immune evasion strategies of influenza viruses. Future Microbiol 5:23-41.
3. O'Hagan DT, Rappuoli R. 2004. Novel approaches to vaccine delivery. Pharm Res 21(9):1519-1530.
4. Kemble G, Greenberg H. 2003. Novel generations of influenza vaccines. Vaccine 21(16):1789-1795.
5. Prausnitz MR, Langer R. 2008. Transdermal drug delivery. Nat Biotechnol 26(11):1261-1268.
6. Raphael AP, Prow TW, Crichton ML, Chen X, Fernando GJ, Kendall MA. 2010. Targeted, needle-free vaccinations in skin using multilayered, densely-packed dissolving microprojection arrays. Small 6(16):1785-1793.
7. Sullivan SP, Koutsonanos DG, Del Pilar Martin M, Lee JW, Zarnitsyn V, Choi SO, Murthy N, Compans RW, Skountzou I, Prausnitz MR. 2010. Dissolving polymer microneedle patches for influenza vaccination. Nat Med 16(8):915-920.
8. Zhu Q, Zarnitsyn VG, Ye L, Wen Z, Gao Y, Pan L, Skountzou I, Gill HS, Prausnitz MR, Yang C, Compans RW. 2009. Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge. Proc Natl Acad Sci U S A 106(19):7968-7973.
9. Roxhed N, Samel B, Nordquist L, Griss P, Stemme G. 2008. Painless drug delivery through microneedle-based transdermal patches featuring active infusion. IEEE Trans Biomed Eng 55(3):1063-1071.
10. Prausnitz MR, Mikszta JA, Cormier M, Andrianov AK. 2009. Microneedle-based vaccines. Curr Top Microbiol Immunol 333:369-393.
11. Hickling J, D'Hondt E. 2006. A review of production technologies for influenza virus vaccines, and their suitability for deployment in developing countries for influenza pandemic preparedness. World Health Organization: Report.
12. Groth N, Montomoli E, Gentile C, Manini I, Bugarini R, Podda A. 2009. Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: A sequential phase I and phase II clinical trial. Vaccine 27(5):786-791.
13. Gregersen JP. 2008. A quantitative risk assessment of exposure to adventitious agents in a cell culture-derived subunit influenza vaccine. Vaccine 26(26):3332-3340.
14. Doroshenko A, Halperin SA. 2009. Trivalent MDCK cell culture-derived influenza vaccine Optaflu (Novartis Vaccines). Expert Rev Vaccines 8(6):679-688.
15. Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, Almagor Y, Sharon O, Levin Y. 2009. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine 27(3):454-459.
16. Reygrobellet C, Viala-Danten M, Meunier J, Weber F, Nguyen VH. 2010. Perception and acceptance of intradermal influenza vaccination: Patient reported outcomes from phase 3 clinical trials. Hum Vaccin 6(4):336-345.
17. Laurent PE, Bonnet S, Alchas P, Regolini P, Mikszta JA, Pettis R, Harvey NG. 2007. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine 25(52):8833-8842.
18. Kim YC, Quan FS, Compans RW, Kang SM, Prausnitz MR. 2010. Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity. J Control Release 142(2):187-195.